Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Heart Health: Marijuana & PAD | WHO warns against use of artificial sweeteners | Plant-based diets | More
Friday, June 16, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Heart Health

Marijuana use linked to much higher risk of peripheral artery disease

New research presented at SCAI Scientific Sessions 2023 suggests that marijuana users should understand the early warning signs of PAD, including feelings of pain and coldness in the leg. 

READ MORE >
The new analysis, based on data from 1.6 million patients, found that a medical marijuana prescription for chronic pain may increase a person's overall arrhythmia risk. Medical marijuana
Share on Twitter Share on Facebook Share on Linkedin

Marijuana use linked to much higher risk of peripheral artery disease

Share on Twitter Share on Facebook Share on Linkedin
The new analysis, based on data from 1.6 million patients, found that a medical marijuana prescription for chronic pain may increase a person's overall arrhythmia risk. Medical marijuana
New research presented at SCAI Scientific Sessions 2023 suggests that marijuana users should understand the early warning signs of PAD, including feelings of pain and coldness in the leg. 
READ MORE >

WHO warns against use of artificial sweeteners, highlighting CVD and diabetes risks

The World Health Organization has published a new guideline recommending against the use of artificial sweeteners such as aspartame and sucralose to lose weight or reduce the risk of noncommunicable diseases.

READ MORE >
The World Health Organization has published a new guideline recommending against the use of artificial sweeteners such as aspartame and sucralose to lose weight or reduce the risk of noncommunicable diseases.
Share on Twitter Share on Facebook Share on Linkedin

WHO warns against use of artificial sweeteners, highlighting CVD and diabetes risks

Share on Twitter Share on Facebook Share on Linkedin
The World Health Organization has published a new guideline recommending against the use of artificial sweeteners such as aspartame and sucralose to lose weight or reduce the risk of noncommunicable diseases.
The World Health Organization has published a new guideline recommending against the use of artificial sweeteners such as aspartame and sucralose to lose weight or reduce the risk of noncommunicable diseases.
READ MORE >

Medtronic acquires insulin patch manufacturer for $738M

The deal represents a significant step forward for Medtronic's diabetes portfolio.

READ MORE >
Business newspaper
Share on Twitter Share on Facebook Share on Linkedin

Medtronic acquires insulin patch manufacturer for $738M

Share on Twitter Share on Facebook Share on Linkedin
Business newspaper
The deal represents a significant step forward for Medtronic's diabetes portfolio.
READ MORE >

Novo Nordisk close to acquiring French medical device company for $165M

The two companies first started collaborating on diabetes technology in 2021. The acquisition is not yet final, but Novo Nordisk now holds the exclusive negotiation rights.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Novo Nordisk close to acquiring French medical device company for $165M

Share on Twitter Share on Facebook Share on Linkedin
The two companies first started collaborating on diabetes technology in 2021. The acquisition is not yet final, but Novo Nordisk now holds the exclusive negotiation rights.
READ MORE >

Plant-based diets—both vegetarian and vegan—linked to lower cholesterol levels, reduced risk of blocked arteries

A new systematic review and meta-analysis of 30 RCTs highlighted numerous benefits associated with vegetarian and vegan diets. Combining a plant-based diet with statin therapy, one researcher noted, could result "in an even larger beneficial effect.”

READ MORE >
Regularly eating avocados is associated with a reduced risk of cardiovascular disease, according to a new study.
Share on Twitter Share on Facebook Share on Linkedin

Plant-based diets—both vegetarian and vegan—linked to lower cholesterol levels, reduced risk of blocked arteries

Share on Twitter Share on Facebook Share on Linkedin
Regularly eating avocados is associated with a reduced risk of cardiovascular disease, according to a new study.
A new systematic review and meta-analysis of 30 RCTs highlighted numerous benefits associated with vegetarian and vegan diets. Combining a plant-based diet with statin therapy, one researcher noted, could result "in an even larger beneficial effect.”
READ MORE >

FDA approves sotagliflozin, the new heart failure drug from Lexicon Pharmaceuticals

The drug, which should be available by the end of June, will be marketed under the name Inpefa.

READ MORE >
approved approval
Share on Twitter Share on Facebook Share on Linkedin

FDA approves sotagliflozin, the new heart failure drug from Lexicon Pharmaceuticals

Share on Twitter Share on Facebook Share on Linkedin
approved approval
The drug, which should be available by the end of June, will be marketed under the name Inpefa.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup